Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T15:15:40.022Z.
Calculation as of: 2026-10-06T15:15:40.022Z.
Quote observation: 2026-10-06T15:14:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 56512602f7675a09d6f7f4200f5a8e0f84a0d0cd58bae79e6b849991cd314651
PEG RATIO
N/A
Market Cap
$136.43M
PEG Ratio
N/A
TTM Avg
517.27
3Y Avg
288.58
5Y Avg
288.58
Market Cap
$147.54M
PEG Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AirSculpt Technologies, Inc. (AIRS) | $141.83M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.09M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | N/A | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | N/A | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $145.57M | N/A | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $145.67M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.43M | N/A | 517.27 | 288.58 | 288.58 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $147.54M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $135.17M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
